arrow
D

David J. McConkey

Johns Hopkins University
H指数:109
被引数:5.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer

撤稿说明:经过重新设计的BCG过量表达环二腺苷酸,增强了训练性免疫,并显示出对膀胱癌的改进效果。

2026-03-230
OAAI
Clinicopathologic and Prognostic Features of Sarcomatoid Urothelial Carcinoma A Retrospective Study of 136 Patients With Emphasis on Early-Stage (pT1) Disease

Li, H.; Parimi, V.; Johnson, B., 3rd; Kamanda, S.; Baraban, E.; Hoffman-Censits, J.; Kates, M.; McConkey, D.J.; Hahn, N.M.; Matoso, A. 肉瘤样尿路上皮癌的临床病理和预后特征:一项针对136例患者的回顾性研究,重点分析早期(pT1)疾病。Am. J. Surg. Pathol. 2025; epub ahead of print. [Google Scholar] [CrossRef] [PubMed]

2026-01-013
PRE
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

肿瘤来源循环肿瘤DNA的动力学变化及其与局部晚期或转移性尿路上皮癌患者对恩诺单抗(Enfortumab)和帕博利珠单抗(Pembrolizumab)临床反应的相关性

2025-12-050
PRE
Intermediate-risk Non–muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group

非肌层浸润性膀胱癌的中危风险:国际膀胱癌小组关于定义、风险分层、管理策略和临床试验设计的建议

2025-10-100
PRE
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer

线粒体能量代谢失调驱动黏膜区域效应向侵袭性膀胱癌的进展

2025-09-250
OAAI
Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model

单细胞RNA测序分析确定了小鼠膀胱癌模型中干扰素 α 基因治疗引起的肿瘤微环境的急性变化

2024-11-040
OAAI
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial
2024-10-011
PRE
Carcinoma Following Neoadjuvant Chemotherapy Oncologic Outcomes in Patients with Residual Upper Tract Urothelial
2024-10-013
PRE
Prognostic Significance of Immune Cell Infiltration in Muscle- invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712
2024-10-010
OA
Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer
2024-08-021
OAAI
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factordefined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2023.05.023
2024-04-011
PRE